Breaking News

Elite Pharma Signs API Supply Pact

December 13, 2012

Obtains adequate supply for Phentermine line

Elite Pharmaceuticals, Inc. has entered an agreement for the next year with its sole supplier of the API for its Phentermine product lines, which include Phentermine HCl tablets 37.5 mg. and Phentermine HCl capsules 15 mg. and 30 mg. A previous supply limitation has been resolved and the purchase orders now in place will allow the company to obtain adequate amounts of API to supply both the Phentermine tablet and Phentermine capsule product, which is scheduled to launch.

Related Contract Manufacturing:

blog comments powered by Disqus
  • API Sourcing Trends

    Kristin Brooks, Contract Pharma||April 11, 2016
    Drug product complexities, quality and regulatory hurdles drive market shift

  • U.S. Pharma Market Trends

    Kristin Brooks, Contract Pharma||April 8, 2016
    CPhI Report sees return of generic and API manufacturing to U.S. market

  • DCAT Week ’16 Session Highlights

    Kristin Brooks, Contract Pharma||March 24, 2016
    API and Dose CMO Market Trends and Supply Strategies